Thalassemia an update: molecular basis, clinical features and treatment

Abstract

Thalassemia are a group of inherited blood disorders caused by the decrease or absence of beta-globin chain synthesis will be determined with decrease in erythrocyte hemoglobin, decreased production of erythrocytes and anemia. More thalassemia is inherited as recessive autosomal. According to this fact that which one of the chains are involved, they invide into two type including alpha and beta thalassemia, which each of them including several types. Thalassemia major is more extensive and patient needs to blood transfusion, but thalassemia minor is slight. The most important problem in this patient include iron overload, cardiac arrhythmia, hepatitis, osteoporosis and endocrine disorder however there are typical signs and symptoms of anemia. Treatment including Change of expression and production of HbF, Hematopoietic stem cell transplantation and Maintenance Treatment such as chelators therapy, Induction of fetal hemoglobin production by using Hydroxia urea, use of immunomodulator agents and Molecular Therapy by targeting of genes involving in HbF expression.in this article we review the thalassemia disorder and discuss on molecular basis, clinical features and treatment.

Authors and Affiliations

Kaveh Tari, Pooya Valizadeh Ardalan, Mahnoosh Abbaszadehdibavar, Amir Atashi, Ali Jalili, Maryam Gheidishahran

Keywords

Related Articles

Epidemiology of malaria in Ramhormoz county, Southwest of Iran, during 2001-2016

Introduction: One of the most important infectious diseases, especially in subtropical and tropical regions in developing countries is Malaria.Due to the importance of the infectious disease in these areas, the aim of cu...

Prevalence and pattern of antibiotic resistance of gram-negative bacteria isolated from urinary tract infections in patients referring to Neka laboratories-Iran

Introduction: Urinary tract infection (UTI) is one of the most common bacterial infections. Increased drug resistance has identified the need to evaluate antibiotic resistance patterns to improve experimental therapy. Th...

Toxoplasmosis in Hemodialysis and Healthy Individuals in Shush County, Southwest of Iran

Introduction:Toxoplasmosis is caused by Toxoplasma gondii. Hemodialysis patients are at higher risk for the toxoplasmosis than healthy people and a rapid and definitive diagnosis is important in these individuals. Thus,...

Role of nutritional supplements in military personnel: a review article

Introduction:Military personnel need to use nutritional supplements to increase physical and mental efficiency and protect against occupational injuries. However, Information is limited about the effectiveness and effici...

The role of folic acid in carcinogenesis, diagnosis, and treatment of cancer

Introduction: Folic acid, also known as folate, is one of the water-soluble B vitamins which its derivatives are involved in many metabolic reactions as cofactor, that are mostly contributed in cell growth. Regarding the...

Download PDF file
  • EP ID EP262280
  • DOI 10.22631/ijbmph.2018.56102
  • Views 88
  • Downloads 0

How To Cite

Kaveh Tari, Pooya Valizadeh Ardalan, Mahnoosh Abbaszadehdibavar, Amir Atashi, Ali Jalili, Maryam Gheidishahran (2018). Thalassemia an update: molecular basis, clinical features and treatment. International Journal of BioMedicine and Public Health (IJBMPH), 0(0), 48-58. https://europub.co.uk./articles/-A-262280